Goodwin

Julie Tibbets

Deals
5
Latest
Aug 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 5 deals
Deals by year
Julie Tibbets: deals by year0520252026 YTD: 4 M&A2026 YTD: 1 Equity raisings52026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Julie Tibbets was named on, most recent first
Aug 2026 Amylyx Pharmaceuticals ––Follow-on offeringLegal adviser to the issuerAnnounced575.2Biotech+1Amylyx Pharmaceuticals equity raising
Apr 2026 CathWorks –MedtronicAcquisitionLegal adviser to CathWorks (target)Announced585.0Medtech+1Medtronic acquisition of CathWorks
Mar 2026 Ouro Medicines –GileadAcquisitionLegal adviser to Ouro Medicines (target)Announced1,675.0Biotech+1Gilead acquisition of Ouro Medicines
Mar 2026 Pikavation SynnovationNovartisAcquisitionLegal adviser to Synnovation Therapeutics (seller)Announced2,000.0Biotech+2Novartis acquisition of Pikavation
Feb 2026 Laysan Bio –Gannet BioChemAcquisitionLegal adviser to Gannet BioChem (acquirer)Announced–Pharma Services+2Gannet BioChem acquisition of Laysan Bio

Deals where Julie Tibbets is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.